SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000849146-21-000106
Filing Date
2021-11-04
Accepted
2021-11-04 16:08:32
Documents
14
Period of Report
2021-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lfvn-20211104.htm   iXBRL 8-K 36298
2 EX-99.1 earningsrelease_q1fy22.htm EX-99.1 211135
6 logoa18a.jpg GRAPHIC 6462
  Complete submission text file 0000849146-21-000106.txt   413638

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20211104.xsd EX-101.SCH 1924
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20211104_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20211104_pre.xml EX-101.PRE 13064
7 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20211104_htm.xml XML 11176
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35647 | Film No.: 211379969
SIC: 2834 Pharmaceutical Preparations